Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Pulmonology
•
Pulmonary Vascular Disease
Do you use anticoagulants in the management of patients with pulmonary veno-occlusive disease (PVOD)?
Related Questions
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
In cases of intermediate-risk pulmonary embolism, what factors influence your decision to pursue catheter-directed thrombolysis?
How do you approach the management of patients with mildly elevated mPAP (21-24 mmHg) and PVR (2-3 WU) who may be at risk of progression, given the recent changes in the hemodynamic definition of pulmonary hypertension?
How do you manage concurrent non-life-threatening hemoptysis and acute pulmonary embolism?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
What are the potential implications of re-introduction of 'long-term responders to calcium channel blockers' in the classification of pulmonary hypertension, and how should clinicians approach the identification and management of these patients?
Have you noticed poor response to Tyvaso DPI compared to the nebulized form in PH-ILD?
How do you approach medication management in biopsy-proven pulmonary sarcoidosis with disease stable for over 2 years on hydroxychloroquine and low dose prednisone?
What are some immunosuppression regimens to consider in a patient with refractory cardiac sarcoidosis?
How do you factor smoking history into biologic selection for asthma since the clinical trials generally excluded these patients?
